Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease,defined by several phases,ranging from benign fat accumulation to non-alcoholic steatohepatitis(NASH),which can lead to liver cancer and...Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease,defined by several phases,ranging from benign fat accumulation to non-alcoholic steatohepatitis(NASH),which can lead to liver cancer and cirrhosis.Although NAFLD is a disease of disordered metabolism,it also involves several immune cell-mediated inflammatory processes,either promoting and/or suppressing hepatocyte inflammation through the secretion of pro-inflammatory and/or anti-inflammatory factors to influence the NAFLD process.However,the underlying disease mechanism and the role of immune cells in NAFLD are still under investigation,leaving many open-ended questions.In this review,we presented the recent concepts about the interplay of immune cells in the onset and pathogenesis of NAFLD.We also highlighted the specific non-immune cells exhibiting immunological properties of therapeutic significance in NAFLD.We hope that this review will help guide the development of future NAFLD therapeutics.展开更多
急性肝衰竭(ALF)是一种罕见但病情凶险的临床综合征,当前治疗以支持治疗和肝移植为主。血浆置换(PEX)作为一种血液净化技术,可清除炎症介质和毒素,是临床广泛应用的肝移植替代治疗方案,已被证实可减轻ALF炎症反应,稳定血流动力学,提高...急性肝衰竭(ALF)是一种罕见但病情凶险的临床综合征,当前治疗以支持治疗和肝移植为主。血浆置换(PEX)作为一种血液净化技术,可清除炎症介质和毒素,是临床广泛应用的肝移植替代治疗方案,已被证实可减轻ALF炎症反应,稳定血流动力学,提高患者生存率。然而,2025年4月在Journal of Hepatology发表的一项英国多中心、回顾性队列研究显示,ALF患者经PEX治疗后,总体生存获益或无移植生存率未见改善,引发学界广泛争论。本文总结了PEX治疗在ALF中的应用进展,并对相关争议问题进行了探讨。展开更多
文摘Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease,defined by several phases,ranging from benign fat accumulation to non-alcoholic steatohepatitis(NASH),which can lead to liver cancer and cirrhosis.Although NAFLD is a disease of disordered metabolism,it also involves several immune cell-mediated inflammatory processes,either promoting and/or suppressing hepatocyte inflammation through the secretion of pro-inflammatory and/or anti-inflammatory factors to influence the NAFLD process.However,the underlying disease mechanism and the role of immune cells in NAFLD are still under investigation,leaving many open-ended questions.In this review,we presented the recent concepts about the interplay of immune cells in the onset and pathogenesis of NAFLD.We also highlighted the specific non-immune cells exhibiting immunological properties of therapeutic significance in NAFLD.We hope that this review will help guide the development of future NAFLD therapeutics.
文摘急性肝衰竭(ALF)是一种罕见但病情凶险的临床综合征,当前治疗以支持治疗和肝移植为主。血浆置换(PEX)作为一种血液净化技术,可清除炎症介质和毒素,是临床广泛应用的肝移植替代治疗方案,已被证实可减轻ALF炎症反应,稳定血流动力学,提高患者生存率。然而,2025年4月在Journal of Hepatology发表的一项英国多中心、回顾性队列研究显示,ALF患者经PEX治疗后,总体生存获益或无移植生存率未见改善,引发学界广泛争论。本文总结了PEX治疗在ALF中的应用进展,并对相关争议问题进行了探讨。
